Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DMAA Warnings Shed Light On FDA NDI Enforcement

This article was originally published in The Tan Sheet

Executive Summary

FDA’s warning letters to 10 marketers of DMAA-containing products might have a silver lining for the supplement industry as they suggest the agency may be flexible on its controversial interpretation of some provisions in the new dietary ingredient notification requirement.

Advertisement

Related Content

Weight Loss Products Provide Ample Targets In FDA War On Spiked Supplements
Weight Loss Products Provide Ample Targets In FDA War On Spiked Supplements
Industry Suggests Increase In Spiked Supplements Reflects FDA Investment In Testing, Targeted Selection
Industry Suggests Increase In Spiked Supplements Reflects FDA Investment In Testing, Targeted Selection
FDA New Dietary Ingredient Rejections Draw “Roadmap” For Successful Notifications
FDA New Dietary Ingredient Rejections Draw “Roadmap” For Successful Notifications
Supplement Safety Critic Cohen Suggests Stronger, Responsive AER System
U.S. Military Investigates Supplement Ingredient DMAA, Bans Sales
Hydroxycut Recall Sheds Light On Pros And Cons Of AER System
Andro Targeted By FDA In Coordination With Capitol Hill Action

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS105727

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel